Guidance for industry : providing regulatory submissions to CBER in electronic format, investigational new drug applications (INDs).

Other author Center for Biologics Evaluation and Research (U.S.)
Format Electronic
Publication InfoRockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2002]
Descriptioni, 22 p. : digital, PDF file
Supplemental Contenthttps://purl.fdlp.gov/GPO/LPS113079
Subjects

Portion of title Providing regulatory submissions to CBER in electronic format, investigational new drug applications (INDs)
General noteTitle from PDF title page (viewed on May 27, 2009).
General note"March 2002".
General noteGPO Cataloging Record Distribution Program (CRDP).
Technical detailsMode of access: Internet at the FDA CBER web site. Address as of 5/27/09: http://www.fda.gov/cber/gdlns/eind.pdf ; current access is available via PURL.
GPO item number0499-T-02 (online)
Govt. docs number HE 20.4802:R 26/6

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available